Literature DB >> 27709684

Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism.

Hale Ates1, Ihsan Ates2, Harun Kundi3, Fatma Meric Yilmaz4.   

Abstract

BACKGROUND: The aim of this study was to determine the hematologic parameter with the highest diagnostic differentiation in the identification of massive acute pulmonary embolism (APE).
METHODS: A retrospective study was performed on patients diagnosing with APE between June 2014 and June 2016. All radiological and laboratory parameters of patients were scanned through the electronic information management system of the hospital. PLR was obtained from the ratio of platelet count to lymphocyte count, NLR was obtained from the ratio of neutrophil count to lymphocyte count, WMR was obtained from white blood cell in mean platelet volume ratio, MPR was obtained from the ratio of mean platelet volume to platelet count, and RPR was obtained from the ratio of red distribution width to platelet count.
RESULTS: Six hundred and thirty-nine patients consisting of 292 males (45.7%) and 347 females (54.3%) were included in the research. Independent predictors of massive risk as compared to sub-massive group were; pulmonary arterial systolic pressure (PASP) (OR=1.40; P=.001), PLR (OR=1.59; P<.001), NLR (OR=2.22; P<.001), WMR (OR=1.22; P<.001), MPR (OR=0.33; P<.001), and RPR (OR=0.68; P<.001). Upon evaluation of the diagnostic differentiation of these risk factors for massive APE by employing receiver operating characteristic curve analysis, it was determined that PLR (AUC±SE=0.877±0.015; P<.001), and NLR (AUC±SE=0.893±0.013; P<.001) have similar diagnostic differentiation in diagnosing massive APE and these two parameters are superior over PASP, MPR, WMR, and RPR.
CONCLUSION: We determined that the levels of NLR and PLR are superior to other parameters in the determination of clinical severity in APE cases.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute pulmonary embolism; massive embolism; neutrophil to lymphocyte ratio; platelet to lymphocyte ratio

Mesh:

Year:  2016        PMID: 27709684      PMCID: PMC6816887          DOI: 10.1002/jcla.22072

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

1.  Evaluation of oxidative stress in the thrombolysis of pulmonary embolism.

Authors:  Diana Mühl; Réka Füredi; Julia Cristofari; Subhamay Ghosh; Lajos Bogár; Balázs Borsiczki; Balázs Gasz; Elizabeth Roth; János Lantos
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

2.  The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients.

Authors:  N Bayrakci; N Ozkayar; F Akyel; I Ates; S Akyel; F Dede
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 3.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

4.  Prognostic value of red cell distribution width in patients with pulmonary embolism.

Authors:  Savas Ozsu; Yasin Abul; Selda Gunaydin; Asim Orem; Tevfik Ozlu
Journal:  Clin Appl Thromb Hemost       Date:  2012-11-08       Impact factor: 2.389

5.  Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study.

Authors:  Mehmet Kayrak; Halil Ibrahim Erdoğan; Yalcin Solak; Hakan Akilli; Enes Elvin Gül; Oğuzhan Yildirim; Murat Erer; Nezire Belgin Akilli; Taha Tahir Bekci; Alpay Aribaş; Mehmet Yazici
Journal:  Heart Lung Circ       Date:  2013-07-12       Impact factor: 2.975

6.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

Review 7.  Pulmonary embolism: risk assessment and management.

Authors:  Stavros Konstantinides; Samuel Z Goldhaber
Journal:  Eur Heart J       Date:  2012-09-07       Impact factor: 29.983

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism.

Authors:  Pierre-Marie Roy; Guy Meyer; Bruno Vielle; Catherine Le Gall; Franck Verschuren; Françoise Carpentier; Philippe Leveau; Alain Furber
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

10.  Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism.

Authors:  Korhan Soylu; Ömer Gedikli; Alay Ekşi; Yonca Avcıoğlu; Ayşegül İdil Soylu; Serkan Yüksel; Okan Gülel; Özcan Yılmaz
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

View more
  7 in total

1.  Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism.

Authors:  Nuri Köse; Tarık Yıldırım; Fatih Akın; Seda Elçim Yıldırım; İbrahim Altun
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

2.  A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism.

Authors:  Jianjun Jiang; Junshuai Xue; Yang Liu
Journal:  J Inflamm Res       Date:  2022-08-18

3.  Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism.

Authors:  Bulent Kantarcioglu; Amir Darki; Fakiha Siddiqui; Emily Krupa; Mehmet Vural; Murat Kacmaz; Debra Hoppensteadt; Omer Iqbal; Walter Jeske; Jeanine Walenga; Cafer Adiguzel; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

4.  Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism.

Authors:  Fakiha Siddiqui; Alberto García-Ortega; Bulent Kantarcioglu; James Sinacore; Alfonso Tafur; Pablo Demelo-Rodríguez; José Antonio Nieto; Esther Usandizaga; Jawed Fareed; Manuel Monreal
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

5.  Relationship Between CHA2DS2-VASc Score and Right Ventricular Dysfunction in Patients With Acute Pulmonary Thromboembolism.

Authors:  Murat Gök; Alparslan Kurtul; Murat Harman; Meryem Kara; Muhammed Süleymanoglu; Ender Ornek
Journal:  Clin Appl Thromb Hemost       Date:  2018-07-11       Impact factor: 2.389

6.  Prognostic value of platelet indices in patients with acute pulmonary thromboembolism.

Authors:  Samad Ghaffari; Nashmil Parvizian; Leili Pourafkari; Ahmad Separham; Reza Hajizadeh; Nader D Nader; Elnaz Javanshir; Nariman Sepehrvand; Arezou Tajlil; Babak Nasiri
Journal:  J Cardiovasc Thorac Res       Date:  2020-02-12

7.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism.

Authors:  Trung Phan; Yevgeniy Brailovsky; Jawed Fareed; Debra Hoppensteadt; Omer Iqbal; Amir Darki
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.